Skip to content

Using a Smart Implantable Device to Compare Early Recovery in Two Different Knee Arthroplasty Approaches

Continuous Monitoring Using a Smart Implantable Device (Persona IQ®) to Compare Medial Parapatellar vs. Subvastus Approaches in Early Post-Operative Total Knee Arthroplasty Recovery

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07348835
Enrollment
110
Registered
2026-01-16
Start date
2026-01-01
Completion date
2027-01-01
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Anthroplasty

Keywords

Total Knee Arthroplasty, Medial Parapatellar Approach, Subvastus Approach

Brief summary

This is a single-institution, prospective, randomized study comparing the medial parapatellar and subvastus approaches in primary total knee arthroplasty using continuous, implant-based gait monitoring. Patients receiving a Zimmer Persona IQ smart implant will be followed preoperatively and through the first 30 days post-operatively, with extended follow-up to 6 months. Preoperative activity is captured using iPhone Health step-count data, while post-operative recovery is assessed using continuous tibial implant data, including step count, range of motion, cadence, walking speed, stride length, and distance. These objective metrics are correlated with PROMs. The primary outcome is daily step count. Secondary outcomes include early functional milestones, pain, and patient-reported functional scores. This study is designed to characterize early recovery trajectories and determine whether meaningful differences exist between surgical approaches.

Interventions

PROCEDURETotal Knee Arthroplasty Medial Parapatellar Approach

Incision splitting quad

PROCEDURETotal Knee Arthroplasty Subvastus Approach

quad-sparing approach

Sponsors

Total Joint Specialists
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

This is a prospective, randomized, parallel-group study. Eligible patients undergoing primary total knee arthroplasty are randomized in a 1:1 ratio to either the medial parapatellar or subvastus surgical approach and followed concurrently. Outcomes are assessed longitudinally.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients older than 18 years of age who plan to undergo medial congruent polyethylene bearing primary TKA with a PIQ * Eligible for both approaches * Have an iPhone and willing to "wear" it for two weeks preoperatively to get an estimated average stepcount * Provide informed consent * Willing to complete follow ups

Exclusion criteria

* Patients with TKA revisions * Patients with insufficient pre-operative range of motion in the operative knee (flexion contracture of \> 20 degrees or \< 90° of knee flexion) * Patients with Contralateral TKA within study time frame * Patients with TKA other than medial congruent polyethylene bearing * Patients with bilateral surgery * Patients without a valid and active email address * Patients not willing or able to participate in study and follow-ups * Patients who use assisted devices to ambulate * Rheumatoid arthritis

Design outcomes

Primary

MeasureTime frameDescription
Step Count (steps/day)Through study completion, minimum 6 monthsContinuously recorded from PIQ device after it is implanted during surgery

Secondary

MeasureTime frameDescription
Stride Length (m)Through study completion, minimum 6 monthsContinuously recorded from PIQ device after it is implanted during surgery
Distance Travelled (km)Through study completion, minimum 6 monthsContinuously recorded from PIQ device after it is implanted during surgery
Functional Range of Motion (degrees)Through study completion, minimum 6 monthsContinuously recorded from PIQ device after it is implanted during surgery
Tibial Range of Motion (degrees)Through study completion, minimum 6 monthsContinuously recorded from PIQ device after it is implanted during surgery
Cadence (steps/minute)Through study completion, minimum 6 monthsContinuously recorded from PIQ device after it is implanted during surgery
Walking Speed (m/s)Through study completion, minimum 6 monthsContinuously recorded from PIQ device after it is implanted during surgery
Goniometric Functional Range of MotionPreoperatively and at 6 weeksMeasured in degrees using a goniometer
Surgical SidePreoperativelyLeft or Right
AgePreoperativelyIn years, from EMR
SexPreoperativelyMale or Female, from EMR
WeightPreoperativelyIn kg, from EMR
HeightPreoperativelyIn cm, from EMR
Body Mass Index (BMI)Preoperativelyin kg/m2, from EMR
ComorbiditiesPreoperativelyCollected and listed from EMR
Charlson Comorbidity Index (CCI)PreoperativelyCalculated from formula using comorbidities collected from EMR
Time to Achieving Key Milestones in Daily Activities6 weeks postoperativelySurvey score collected (less time = better), Survey via Force Therapeutics
Veterans Rand 12-Item (VR-12) Health SurveyPreoperatively, 6 weeks postoperatively, 6 months postoperativelyMental and Physical component survey scores collected (0-100); Survey via Force Therapeutics
Numeric Pain Rating Scale (NPRS)Preoperatively, 6 weeks postoperativelySurvey score collected (0-10; 0 best), Survey via Force Therapeutics
Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR.)Preoperatively, 6 weeks postoperatively, 6 months postoperativelySurvey score collected (0-100; 100 best), Survey via Force Therapeutics
Procedure Satisfaction6 weeks postoperativelySurvey score collected (0-5; 5 best), Survey via Force Therapeutics
Forgotten Joint Score (FJS)Preoperatively, 6 weeks postoperatively, 6 months postoperativelySurvey score collected (0-100; 100 best), Survey via Force Therapeutics

Countries

United States

Contacts

CONTACTThomas L Bradbury, M.D.
tombradburymd@gmail.com(404)-759-3912

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026